Literature DB >> 27659598

Body Mass Index and Total Psoas Area Affect Outcomes in Patients Undergoing Pneumonectomy for Cancer.

Remi Hervochon1, Antonio Bobbio1, Claude Guinet2, Audrey Mansuet-Lupo3, Antoine Rabbat4, Jean-François Régnard5, Nicolas Roche6, Diane Damotte3, Antonio Iannelli7, Marco Alifano8.   

Abstract

BACKGROUND: Hypothesizing that morphometric measurements are reliable markers of fitness in patients with lung cancer requiring aggressive surgical intervention, the purpose of this study was to assess their impact on postoperative outcome and long-term survival in patients with non-small cell lung cancer (NSCLC) requiring pneumonectomy.
METHODS: Height, weight, and body mass index (BMI), as well as usual clinical, laboratory (including C-reactive protein [CRP] concentrations), and pathologic data were retrospectively retrieved from files of 161 consecutive patients treated by pneumonectomy for NSCLC, whose preoperative computed tomographic (CT) scans were available in the Picture Archive and Communication System (PACS) of the hospital. Cross-sectional areas of right and left psoas areas (measured by CT scan at the L3 level), perirenal fat thickness, and anterior subcutaneous tissue thickness at the left renal vein level were also assessed.
RESULTS: BMI and total psoas area were strongly and directly correlated (p = 0.0000001), whereas BMI was inversely related to CRP levels. Sarcopenia (total psoas area ≤33rd percentile) was associated with high CRP levels (>20 mg/L) (p = 0.010). Factors associated with 90-day mortality included older age (p = 0.000045), lower body weight (p = 0.032), and BMI less than or equal to 25 kg/m2 (p = 0.013). At univariate analysis, long-term outcome was negatively affected by a nonsquamous cell histologic type (p = 0.011), pathologic stage IIIB-IV (p =0.026), CRP levels greater than 20 mg/L (p = 0.017), BMI less than or equal to 25 kg/m2 (p = 0.010), and total psoas area less than or equal to the 33rd percentile (p = 0.029). Multivariate analysis showed the independent prognostic value of both BMI and total psoas area.
CONCLUSIONS: BMI less than or equal to 25 kg/m2 and total psoas cross-sectional area less than or equal to the 33rd percentile are prognostic determinants in patients with NSCLC requiring pneumonectomy.
Copyright © 2017 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27659598     DOI: 10.1016/j.athoracsur.2016.06.077

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  24 in total

1.  Sarcopenia in resected non-small cell lung cancer: let's move to patient-directed strategies.

Authors:  Philippe Icard; Antonio Iannelli; Hubert Lincet; Marco Alifano
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

2.  Perspective: Do Fasting, Caloric Restriction, and Diets Increase Sensitivity to Radiotherapy? A Literature Review.

Authors:  Philippe Icard; Luc Ollivier; Patricia Forgez; Joelle Otz; Marco Alifano; Ludovic Fournel; Mauro Loi; Juliette Thariat
Journal:  Adv Nutr       Date:  2020-09-01       Impact factor: 8.701

3.  Sarcopenia predicts poor postoperative outcome in elderly patients with lung cancer.

Authors:  Yo Kawaguchi; Jun Hanaoka; Yasuhiko Ohshio; Keigo Okamoto; Ryosuke Kaku; Kazuki Hayashi; Takuya Shiratori; Makoto Yoden
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-04-10

4.  Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium.

Authors:  Daniel Shepshelovich; Wei Xu; Lin Lu; Aline Fares; Ping Yang; David Christiani; Jie Zhang; Kouya Shiraishi; Brid M Ryan; Chu Chen; Ann G Schwartz; Adonina Tardon; Xifeng Wu; Matthew B Schabath; M Dawn Teare; Loic Le Marchand; Zuo-Feng Zhang; John K Field; Hermann Brenner; Nancy Diao; Juntao Xie; Takashi Kohno; Curtis C Harris; Angela S Wenzlaff; Guillermo Fernandez-Tardon; Yuanqing Ye; Fiona Taylor; Lynne R Wilkens; Michael Davies; Yi Liu; Matt J Barnett; Gary E Goodman; Hal Morgenstern; Bernd Holleczek; M Catherine Brown; Geoffrey Liu; Rayjean J Hung
Journal:  J Thorac Oncol       Date:  2019-06-01       Impact factor: 15.609

5.  Sarcopenia is related to poor prognosis in patients after trimodality therapy for locally advanced non-small cell lung cancer.

Authors:  Kuniaki Katsui; Takeshi Ogata; Kenta Watanabe; Kotaro Yoshio; Masahiro Kuroda; Masaomi Yamane; Takao Hiraki; Katsuyuki Kiura; Shinichi Toyooka; Susumu Kanazawa
Journal:  Int J Clin Oncol       Date:  2021-04-20       Impact factor: 3.402

Review 6.  Implications of low muscle mass across the continuum of care: a narrative review.

Authors:  Carla M Prado; Sarah A Purcell; Carolyn Alish; Suzette L Pereira; Nicolaas E Deutz; Daren K Heyland; Bret H Goodpaster; Kelly A Tappenden; Steven B Heymsfield
Journal:  Ann Med       Date:  2018-09-12       Impact factor: 4.709

7.  Systemic immune-inflammation index and prognosis of advanced non-small cell lung cancer.

Authors:  Marco Alifano
Journal:  Ann Transl Med       Date:  2020-06

8.  Prognostic factors after pulmonary metastasectomy of colorectal cancers: a single-center experience.

Authors:  Ludovic Fournel; Stefania Maria; Marie Seminel; Jessica Nesci; Audrey Mansuet-Lupo; Claude Guinet; Pierre Magdeleinat; Antonio Bobbio; Jean-François Regnard; Marco Alifano
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

9.  Sarcopenia is a predictor of outcomes after lobectomy.

Authors:  James A Miller; Kassem Harris; Charles Roche; Samjot Dhillon; Athar Battoo; Todd Demmy; Chukwumere E Nwogu; Elisabeth U Dexter; Mark Hennon; Anthony Picone; Kristopher Attwood; Sai Yendamuri
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

10.  Low thoracic muscle mass index on computed tomography predicts adverse outcomes following lobectomy via thoracotomy for lung cancer.

Authors:  Hüseyin Ulaş Çınar; Burçin Çelik; Gülten Taşkın; Özgür İnce
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.